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ABSTRACT Nef, an accessory protein from human immunodeﬁciency virus type 1, is critical for optimal viral replication and
pathogenesis. Here, we analyzed the inﬂuence of full-length myristoylated and nonmyristoylated Nef on artiﬁcial lipid bilayers
composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC). By means of cosedimentation assays, we found that
neither nonmyristoylated nor myristoylated Nef stably binds to POPC unilamellar vesicles. Time-resolved ellipsometry rather indi-
cates that the proteins perturb the assembly of POPC planar bilayers. This observation was corroborated by ﬂuorescence and
scanning force microscopy, suggesting that membrane disordering occurs upon interaction of full-length myristoylated and non-
myristoylated Nef with planar POPC membranes immobilized on SiO2 surfaces resulting in loss of material from the surface. The
membrane perturbations were further investigated by vesicle release experiments, demonstrating that the disordering results in
defects through which the ﬂuorophor carboxyﬂuorescein can pass. From these results, we conclude that Nef is capable of
disordering and perturbing lipid membranes and that the myristoyl group is not the decisive determinant for the action of the
protein on lipid membranes.INTRODUCTION
The human immunodeficiency virus type 1 (HIV-1) Nef
protein is an N-terminally myristoylated protein of 24–32
kDa size that belongs to the so-called accessory proteins of
HIV (1,2). Several functions have been attributed to Nef,
which can in principle be classified into three categories:
1), alteration of cell-surface exposure of receptor molecules
such as CD4 and MHC I, 2), modulation of signal-transduc-
tion pathways, and 3), enhancement of virus infectivity (as
reviewed in (3–6)). Hence, in individuals infected with
Nef-deficient viruses, a significantly delayed disease
progression is observed (7–9).
It is supposed that the functions of Nef that mediate the
alteration of signaling and trafficking pathways require its
membrane association. This targeting is mediated by an
N-terminal myristoylation site, which is essential for
membrane attachment (10,11). Although all Nef alleles
contain the highly conserved myristoylation motif, it is also
observed in cellular fractionation assays from transient
transfections that <40% of all Nef protein is localized at
membranes, whereas the majority is found in the cytosol
(11–15). It is not known whether these two populations of
Nef represent a dynamic equilibrium, in which individual
Nef molecules shuttle on and off the membrane or whether
they are distinct biochemical species with different functions.
Arold and Baur (16) speculated that after translation, Nef
adopts a ‘‘closed conformation’’ to hide potential binding
sites and to prevent proteolytic digestions of its flexible
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interact with a hydrophobic region on the core domain, which
could explain why the majority of the protein is localized in
the cytosol and not attached to membranes. However, myris-
tic acid is a short fatty acid (C14) and therefore forms only
a weak membrane anchor when it is exposed. Accordingly,
myristoylation is often not sufficient to target a protein stably
into a lipid bilayer (17,18).
Here,we addressed the questionof how themyristoyl anchor
of HIV-1 Nef influences its interaction with lipid membranes
in vitro. By means of vesicle cosedimentation assays and
time-resolved ellipsometry, we studied the binding properties
of wild-type (wt) Nef in comparison to the mutant Nef G2A
lacking the myristoyl anchor (Fig. 1) to 1-palmitoyl-2-oleoyl-
sn-glycero-3-phosphocholine (POPC) lipid bilayers. Unex-
pectedly, we observed an interaction with the membrane that
was independent of the myristoylation state of Nef. Moreover,
instead of stable membrane association, Nef induced
membrane perturbations resulting in the detachment of lipids
from the surface. To investigate this in more detail, release
experiments on large unilamellar vesicles (LUVs) as well as
fluorescence and scanning forcemicroscopy imagingwere per-
formed that allowed to visualize the membrane alterations.
MATERIALS AND METHODS
Materials
POPC was purchased from Avanti Polar lipids (Alabaster, AL). Sulforhod-
amine 101 dihexadecanoylphosphatidylethanolamine (DHPE) was obtained
from Sigma Aldrich (Taufkirchen, Germany). Fluorescein isothiocyanate
(FITC)-conjugated rabbit anti-6xHIS antibody was from Dunn Labortechnik
(Asbach, Germany). The silicon substrates were obtained from Si-Mat
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phadex G-25 column was purchased from Biotech AB (Uppsala, Sweden).
Water was purified first through a Millipore water-purification system Milli-
RO 3 plus and finally with a Millipore ultrapure water system Milli-Q plus
185 (specific resistance ¼ 18.2 MU/cm) (Billerica, MA).
Protein preparation
Myristoylated wt Nef protein, HIV-1 allele SF2 (AC:K02007), was prepared
in Escherichia coli BL21(DE3) cells from a codon optimized plasmid by
coexpression with the N-myristoyl transferase and addition of myristic acid
as substrate, similarly as described (19). The protein contained a C-terminal
hexahistidine tag for purification by nickel affinity chromatography.Nonmyr-
istoylated Nef G2A was polymerase chain reaction-amplified with NcoI/
HindIII restriction sites and cloned into the pET-23d expression vector
(Novagen) and expressed without the N-myristoyl transferase. The accuracy
of all plasmid constructs was confirmed by nucleotide sequencing. Full myr-
istoylation was confirmed by ESI analytical mass spectrometry. All proteins
were concentrated to ~10mg/ml in 20mMTris/HCl buffer (pH8)with 50mM
NaCl, 1 mM DTE, aliquoted, shock frozen, and stored at 80C.
Vesicle preparation
Lipid films composed of POPC or POPC doped with 0.1 mol % sulforhod-
amine 101 DHPE were prepared at the bottom of glass test tubes by drying
the lipids dissolved in chloroform under a stream of nitrogen while heating
above 30C followed by 3 h under vacuum. The lipid films were stored at
4C. To obtain multilamellar vesicles, a lipid film was incubated in buffer
solution (20 mM Tris/HCl, 100 mM NaCl, pH 7.4) for 30 min followed
by vortexing it three times for 30 s every 5 min. The resulting multilamellar
vesicles were converted into LUVs by the extrusion method using a polycar-
bonate membrane with a pore diameter of 100 nm (20).
For release measurements, multilamellar vesicles were prepared as
mentioned above, but the buffer solution contained additional 100 mM
5(6)-carboxyfluorescein (CF). After formation of LUVs, the external
fluorescence dye was removed from the vesicles by gel filtration using
a Sephadex G-25 column.
Preparation of solid-supported membranes on
SiO2 surfaces
First, the silicon substrates were cleaned with isopropanol and ultrapure
water. Then, they were incubated in an aqueous solution of NH3 and H2O2
(5/1/1H2O/NH3/H2O2) for 15min at 70
C. Finally, the substrateswere rinsed
with ultrapure water.
For preparation of solid-supported membranes on silicon dioxide, the
well-known technique of spreading and fusion of unilamellar vesicles on
hydrophilic surfaces was used as described (21–23). For fluorescence and
scanning force microscopy images, the substrates were placed in an open
Teflon cell and incubated with the vesicle suspension (0.05 mg/mL) for
1 h at room temperature. Remaining vesicles were removed by rinsing the
surface with a buffer flow (20 mM Tris/HCl, 100 mM NaCl, 1 mM dithio-
threitol (DTT), pH 7.4).
For ellipsometry experiments, the silicon substrates were placed in a fluid
cell (Nanofilm Technologie, Go¨ttingen, Germany). The cell was filled with
FIGURE 1 Amino acid sequences of melittin and the N-terminus of full-
lengthHIV-1wtNef and the correspondingmutantNefG2A. Identical residues
of melittin and wt Nef are shown in shaded boxes, and analogous residues are
marked in open boxes. Basic residues are highlighted in bold.buffer solution (20 mM Tris/HCl, 100 mM NaCl, pH 7.4), and POPC vesi-
cles (0.2 mg/mL) were continuously pumped through the cell by a peristaltic
pump with a velocity of 0.5 mL/min for 1 h at room temperature. The
remaining vesicles were removed by rinsing the cell with buffer solution
(20 mM Tris/HCl, 100 mM NaCl, 1 mM DTT, pH 7.4) for 30 min.
Vesicle cosedimentation assay
Freshly prepared LUVs (0.5 mg/mL) were incubated at 4C overnight with
HIV-1 wt Nef and HIV-1 Nef G2A, respectively. Lipid/protein of 365:1 and
65:1 was chosen. Then, the LUVs were centrifuged at 4C and 232,000 g
for 1 h, and a sample was taken from the supernatant. After the supernatant
was carefully removed, the vesicle pellet was redissolved in buffer (20 mM
Tris/HCl, 100 mM NaCl, pH 7.4) and centrifuged at 4C and 232,000  g
for 1 h. Samples were taken from the supernatant and the pellet. All samples
were treated with 0.175 M Tris/HCl, 5% SDS (w/v), 15% glycerol (v/v),
0.06 g/L bromphenol blue, and 0.3 M DTT at pH 6.8 and heated for
5 min at 95C. Equivalent amounts of the supernatant fractions and the pellet
were analyzed with sodium dodecyl sulfate-polyacrylamide gel electropho-
resis (SDS-PAGE). The SDS-polyacrylamide gels (17%) were stained with
Coomassie brilliant blue.
Ellipsometry
Ellipsometry is a well-known technique for the characterization of thin films
(24–27). To observe a change in membrane film thickness as a result of
membrane-protein interactions, experiments were carried out using a Nano-
film EP3 ellipsometer (Nanofilm Technologie, Go¨ttingen, Germany). The
instrument was equipped with a laser emitting at a wavelength of 636.7 nm.
The angle of incidencewas set to 60. The resulting ellipsometric angles delta
and psi were recorded as a function of time using the one zone nulling proce-
dure. The membrane film thickness was calculated based on a model
composed of bulk silicon followed by silicon dioxide, onwhich a lipid bilayer
was deposited. The refractive indices for doped silicon, silicon dioxide, and
water were taken from a database included in the software (LayTec, Berlin,
Germany). The refractive index for water was applied for the buffer solution,
as the low salt concentration does not significantly influence the refractive
index. The refractive index for a lipid bilayer was taken from literature (27).
Fluorescence microscopy
For fluorescence microscopy, planar POPC membranes were doped with
0.1 mol % sulforhodamine 101 DHPE. After addition of protein and incuba-
tion overnight at 4C, the samples were rinsed with buffer solution, and fluo-
rescence images were taken using an AxioTech Vario (Zeiss, Go¨ttingen,
Germany) fluorescence microscope equipped with a 40 or 63 water
immersion objective (ACHROPLAN, na ¼ 0.8 water, Zeiss, Hamburg,
Germany). To follow the fluorescence of sulforhodamine 101 DHPE the
filter set 45 (Zeiss, Go¨ttingen, Germany) and of FITC-conjugated rabbit
anti-6xHIS antibody the filter set 44 (Zeiss, Go¨ttingen, Germany) was used.
Scanning force microscopy
Scanning force microscopy was performed using a JPK NanoWizard II scan-
ning force microscope (JPK Instruments, Berlin, Germany). All images were
obtained in aqueous solution in contact mode using silicon cantilevers
(CSC 38) from Ultrasharp (Moscow, Russia) with a nominal spring constant
of 0.03 N/m with a typical scan rate of 0.5 Hz and a scan angle of 90. Image
resolution was 512  512 pixels.
CF release from lipid vesicles
CF release from LUVs composed of POPC was followed by monitoring the
increase of the fluorescence signal F(t) as a function of time after the addi-
tion of HIV-1 wt Nef and HIV-1 Nef G2A. All experiments were performed
with a fluorometer (FP 6500 Jasco, Gotha, Germany). CF fluorescence wasBiophysical Journal 96(8) 3242–3250
3244 Szilluweit et al.measured using an excitation wavelength of 490 nm (slit width: 5 nm) and an
emission wavelength of 520 nm (slit width: 5 nm). The maximum fluores-
cence intensity signal Ft was determined after the addition of 2 mL Triton
X-100 (10% (w/w)) to a total volume of 600 mL, which destroys the vesicles.
The normalized fluorescence Frel defined as (Eq. 1):
FrelðtÞ ¼ FðtÞ  F0
Ft  F0 (1)
is plotted as a function of time, with F0 being the fluorescence intensity
before the addition of protein. All measurements were performed in 20 mM
Tris/HCl, 100 mM NaCl, 1 mM DTT, pH 7.4 at room temperature.
RESULTS
Interaction of HIV-1 Nef with lipid vesicles
It is thought that the biological activities ofNef require its asso-
ciation with cellular membranes and that this interaction is
mediated by its N-terminal myristoylation. To investigate
whether myristoylation is the only requirement for membrane
association in vitro, we performed cosedimentation assays
using LUVs. POPC-LUVs were incubated with HIV-1 Nef
wt and HIV-1 Nef G2A, which lacks the myristoyl acceptor
glycine at position 2 and therefore is not myristoylated. After
centrifugationof thevesicles, the supernatants andpelletswere
analyzed by SDS-PAGE (Fig. 2). HIV-1 wt Nef as well as
HIV-1NefG2Awere only found in the supernatants (S1, lanes
2 and 5), whereas no protein was detected in the vesicle pellet.
This suggests that a strong interaction of the protein to the
membrane does not occur irrespective of the presence of the
myristic acid moiety. Because it has been proposed that a
subpopulation of Nef resides in detergent-resistant membrane
microdomains or lipid rafts (15,28–30), we performed the
same experiment with a lipid mixture that resembles rafts,
namely POPC/sphingomyelin/cholesterol in a 2:1:1 ratio.
However, a similar result as for POPC-LUVs was obtained;
neither wt Nef nor Nef G2A was found in the vesicle pellet
(Fig. 2 B), suggesting that no stable interaction between the
protein and the lipid bilayer takes place.
Interaction of HIV-1 Nef with planar bilayers
As the vesicle cosedimentation assay only shows the amount
of protein stably bound to themembranes, we next used planar
lipid bilayers on silicon substrates. Thesemembranes allow for
the detection of protein binding in a time-resolved manner by
monitoring changes in thickness by means of ellipsometry.
First, LUVs composed of POPC were spread on silicon
dioxide surfaces. The bilayer formation process was observed
bymeasuring the changes of the ellipsometric angles delta and
psi as a function of time (data not shown). From delta and psi,
themembrane film thicknesswas calculated using the software
LayTec. A mean lipid bilayer thickness of (6.3  0.8) nm
(n¼ 12) was obtained. The value demonstrates the formation
of planar POPC bilayers on the silicon substrates. After the
bilayer had been established, 0.5 mM HIV-1 wt Nef and
0.5 mMHIV-1 Nef G2A, respectively, were added and contin-Biophysical Journal 96(8) 3242–3250uously pumped through the cell by a peristaltic pump with
a velocity of 0.5mL/min for 1 h at room temperature, followed
by rinsing the samplewith buffer solution for 30min to remove
nonbound protein.
Surprisingly, in none of the experiments an increase in
film thickness upon addition of the protein was monitored,
suggesting that protein binding to the membrane does not
occur or that it occurs only transiently. Instead, a decrease
in film thickness was observed after protein addition. Two
typical time courses of the change in membrane film thick-
ness after the addition of HIV-1 wt Nef and HIV-1 Nef
G2A are depicted in Fig. 3. The addition of HIV-1 wt Nef
FIGURE 2 SDS-PAGE analysis of the cosedimentation assays of POPC-
LUVs and either HIV-1 wt Nef (wt) or HIV-1 G2A (G2A) (A). Panel B shows
the result of an SDS-PAGE analysis of the cosedimentation assay of POPC/
sphingomyelin/cholesterol 2:1:1 LUVs and either HIV-1 wt Nef (wt) or
HIV-1G2A(G2A). Proteinswere visualizedbyCoomassie staining.M,protein
marker; S1, supernatant; S2, supernatant after washing; and P, pellet.
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9.0% after the addition of the protein. Rinsing with buffer
solution decreased the membrane thickness further by
~2.1%. On average, a decrease in membrane thickness of
(9  4)% was observed (Table 1). Immediately after the
addition of HIV-1 Nef G2A (Fig. 3 B), the film thickness
decreased by 29.1%. No further decrease in thickness was
observed after rinsing with buffer solution. From five inde-
pendent measurements, an average change in membrane
thickness of (30  7)% was observed (Table 1). We attribute
this decrease in membrane thickness to a destabilization of
FIGURE 3 Ellipsometry measurements showing the change of POPC
membrane thickness after addition of 0.5 mM HIV-1 wt Nef (A) and 0.5 mM
HIV-1 Nef G2A (B) and rinsing with buffer solution. The time point of
addition of the protein is marked as t ¼ 0.
TABLE 1 Average decrease in membrane ﬁlm thickness after
the addition of HIV-1 Nef
Protein Decrease in film thickness (%)
HIV-1 wt Nef 9  4 (n ¼ 7)
HIV-1 Nef G2A 30  7 (n ¼ 5)the lipid bilayer presumably resulting in a detachment of
lipids from the silicon dioxide surface upon interaction
with myristoylated and nonmyristoylated Nef.
Visualization of membrane disordering by
ﬂuorescence microscopy
To get further information about the lipid destabilization
process and to visualize a possible lipid detachment from
the surface, we used fluorescence in conjunction with scan-
ning force microscopy on planar lipid membranes composed
of POPC immobilized on silicon dioxide surfaces. For a fluo-
rescence inspection of the formed membranes, they were
dopedwith 0.1mol% sulforhodamine 101DHPE.Ahomoge-
neous fluorescence as shown in Fig. 4 A indicates a complete
bilayer with no defects. Only to defect-free POPC-bilayers
Nef protein was added. HIV-1 wt Nef was added at different
concentrations under flow and static conditions (see the
Supporting Material). Incubation at a final concentration of
1.0 mM and rinsing with buffer solution to remove nonbound
protein from solution results in the fluorescence images as
shown in Fig. 4 C. A nonhomogeneous fluorescence became
discernable with a large number of black spots.
To rule out that the membrane changed its appearance as
a result of the incubation time, the same experiment was per-
formedwithout addition ofHIV-1wtNef as control (Fig. 4B).
No inhomogeneity of the fluorescence signal was observed
even after 14 h incubation time. To investigate if protein is
localized in the dark areas, where fluorescently labeled lipids
are no longer present or if these areas are free of lipid and
protein, the sample was incubated with FITC-conjugated
rabbit anti-6xHIS antibody (1:250) for 2 h at room tempera-
ture. After rinsing with buffer solution to remove nonbound
antibody, fluorescence images were taken (Fig. 4 D). An
almost perfect overlay of the nonfluorescent regions in the
membrane and the positions of the antibody (compare
Fig. 4, C and D) was found suggesting the presence of Nef.
In a similar set of experiments the influence of HIV-1 Nef
G2A on planar POPC membranes immobilized on silicon
dioxide was investigated. Similar results were obtained
(Fig. 5). After incubation of the membranes with HIV-1 Nef
G2A, black spots appeared in the membrane indicative of
its destabilization and disordering. Incubation with the
FITC-conjugated rabbit anti-6xHIS antibody (1:250) resulted
in a fluorescence labeling of the areas of the dark spots. The
average size of these dark spots ranged from 1 to 5 mm.
Control experiments, in which the antibody was added to
a pure POPC bilayer, did not show any nonspecific binding
of the antibody to POPC (data not shown). Also, the addition
of a nonspecific FITC labeled antibody did not result in
a significant fluorescence (see the Supporting Material) as
observed in the case of the specific antibody. Only a faint fluo-
rescence was observed, which does not match the nonfluores-
cent regions in the membranes. From these experiments, we
conclude that the interaction of the FITC-conjugated rabbitBiophysical Journal 96(8) 3242–3250
3246 Szilluweit et al.FIGURE 4 Fluorescence micrographs of a sulforhodamine 101 DHPE-
doped POPC membrane. (A) Membrane before the addition of HIV-1
wt Nef. (B) Control, in which the membrane was incubated overnight at
4C without adding protein. (C) Membrane after the addition of 1.0 mM
HIV-1 wt Nef and incubation overnight at 4C. (D) FluorescenceBiophysical Journal 96(8) 3242–3250anti-6xHIS antibody is specific for Nef and does not interact
nonspecifically with the perturbed membrane structures.
Visualization of membrane disordering by
scanning force microcopy
To obtain a higher resolution of the observed disordered
membrane structures, scanning force microscopy images of
the same POPC bilayers that were inspected by fluorescence
microscopy were taken before and after 1.0 mM HIV-1 Nef
was added. Before the addition of protein, a homogeneous
membrane was visualized without any apparent perturbation
of its surface texture (data not shown). After the lipid bilayer
was incubated with the protein and unbound protein was
micrograph after the addition of FITC-conjugated rabbit anti-6xHIS anti-
body (1/250) and incubation for 2 h at room temperature. The insets show
magnifications of the corresponding figure. All scale bars are 20 mm.
FIGURE 5 Fluorescence micrographs of a sulforhodamine 101 DHPE-
doped POPC membrane. (A) Membrane after the addition of 1.0 mM HIV-1
Nef G2A and incubation overnight at 4C. (B) Fluorescence micrograph after
the addition of FITC-conjugated rabbit anti-6xHIS antibody (1:250) and
incubation for 2 h at room temperature. The insets show magnifications of
the corresponding figure. All scale bars are 20 mm.
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topography of the bilayers had considerably changed.
Fig. 6,A andB, shows the topography of the bilayer after addi-
tion of HIV-1 wt Nef. Brighter areas are discernable, which
are similar in size and frequency as the black spots observed
in fluorescence microscopy of the same sample. The higher
structure unambiguously indicates that protein is located
within these areas. Similar results were obtained for HIV-1
Nef G2A (Fig. 6, C and D). The membrane surface was
covered with round domains with a slightly higher topog-
raphy. In general, the membranes appeared soft and were,
due to their softness, difficult to image. There was no depen-
dence of the distribution and appearance of the disordered
membrane structures on whether wt or G2A Nef was used
(see the Supporting Material).
Release of CF induced by HIV-1 Nef
From the obtained results, we conclude that HIV-1 Nef
interacts with POPC membranes in such that it disturbs the
organization of the lipid bilayers eventually resulting in the
detachment of lipids from a solid substrate as described above.
To address whether the perturbation of themembrane induced
by the action of HIV-1 Nef results in holes through which
molecules can pass, release-experiments using CF filled
LUVs were performed. The CF release method has been
shown to bewell suited to study the formation of holes in vesi-
cles induced by peptides and proteins (31–34). It relies on theself-quenching of encapsulated CF. When a pore forms in
a vesicle containing internal CF, its release is detected as an
increase in fluorescence intensity. The fluorescence signal
of CF was measured at a wavelength of 520 nm in a time-
resolved manner. After a stable baseline was reached, HIV-
1 wt Nef was added to the vesicle suspension resulting in
molar lipid/protein of 65:1. Themaximumfluorescence inten-
sity was obtained by disrupting the vesicles by adding Triton
X-100. Fig. 7 A shows a characteristic increase of the fluores-
cence signal upon addition of HIV-1 wt Nef to POPC LUVs.
After the addition of HIV-1 wt Nef, an increase of 14.7% of
the fluorescence signal was observed indicating that some
vesicles became leaky, thus releasing the fluorophor. To
investigate the influence of the myristic acid moiety on the
lipid perturbation, the same experiment was performed with
HIV-1 Nef G2A. In this case, 22.7% of the entrapped dye
was released. On average, a dye release of (12  4)% was
observed for HIV-1 wt Nef, whereas for HIV-1 Nef G2A
the average increase of the fluorescence signal amounted to
(14  4)% (Table 2). From these results, it can be concluded
that the myristoylation is not the decisive parameter for the
formation of holes through which the dye can pass.
DISCUSSION
In this study, we investigated the influence of full-length Nef
from HIV-1 on lipid membranes with emphasis on the impactFIGURE 6 Scanning force micros-
copy images showing the topography
(contact mode) of a POPC membrane
attached to a silicon dioxide surface
after the addition of 1.0 mM HIV-1 wt
Nef (A and B) and 1.0 mM HIV-1 Nef
G2A (C and D) Scale bar: A and C,
5 mm; B and D, 1 mm.
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tation assays, the binding ability of myristoylated HIV-1
wt Nef and the nonmyristoylated mutant Nef G2A to
membranes was elucidated. Surprisingly, no stable binding
to membranes was monitored even in the presence of the
myristoyl anchor. This was corroborated by time-resolved
ellipsometry measurements on lipid bilayers attached to
silicon dioxide surfaces. Instead, both proteins perturb the
membranes, which results in a decrease in membrane thick-
ness. This decrease might result from a net loss of material,
i.e., removal of lipids, from the surface (see Fig. 3). The over-
all amount of released material, however, cannot be quanti-
FIGURE 7 Release of CF from POPC vesicles as a function of time after
the addition of HIV-1 wt Nef (A) and HIV-1 Nef G2A (B). Lipid/protein of
65:1 was used. The fluorescence signal has been normalized according to
Eq. 1. Protein has been added at t ¼ 0.
TABLE 2 Average increase of the ﬂuorescence signal after the
addition of HIV-1 Nef to POPC LUVs with lipid/protein of 65:1
Protein Increase of the fluorescence signal (%)
HIV-1 wt Nef 12  4 (n ¼ 20)
HIV-1 Nef G2A 14  4 (n ¼ 20)Biophysical Journal 96(8) 3242–3250fied, as in the areas, where no lipids are present, Nef protein
is found (Figs. 4–6), which is discussed in more detail below.
Earlier experiments by Curtain et al. (35) using nonmyris-
toylated Nef already suggested membrane perturbations. In
this previous study, light-scattering as well as membrane-
fusion experiments were performed. Lipid mixing was
observed as well as an increase in light scattering indicating
disturbance of the vesicle structure if N-terminal peptides of
Nef and nonmyristoylated Nef interacted with lipid vesicles.
However, all experiments were performed with small unila-
mellar vesicles composed of 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine,which are in the gel state at room temperature
and thus are nonphysiological. In cellular experiments, Fujii
et al. (36) found that the addition of recombinant, nonmyris-
toylated HIV-1 Nef at low concentrations inhibits the growth
of CD4þ cells, whereas it leads to cell death at higher concen-
trations. Short N-terminal HIV-1 Nef fragments composed of
at least the first 22 amino acids added to yeast and bacterial
cells turned out to be cytotoxic (37,38). The addition of amyr-
istoylated N-terminal fragment to yeast cells results in total
loss of colony formation, whereas the addition of a nonmyris-
toylated fragment results in only 80% loss. These observa-
tions were discussed in terms of a Nef-induced membrane
disruption, which results in loss of membrane into the extra-
cellular media. All conclusions are corroborated by the
sequence similarity (Fig. 1) of the N-terminus of wt Nef and
melittin, a highlymembrane active peptide (39). The decrease
in membrane thickness as monitored by ellipsometry as well
as the membrane perturbations observed by fluorescence
and scanning force microscopy observed in this study
confirms and extends these findings, as it reveals that lipids
get disordered by full-length Nef, presumably leading to their
detachment from the solid substrate. Membrane perturbations
result in the exposure of the silicon dioxide surface and hydro-
phobic regions of the membrane leading to a different ‘‘artifi-
cial’’ adsorption site for the protein. These adsorption sites are
not created in lipid vesicles, because, first, no underlying
silicon dioxide is present, and, second, the perturbations are
probably less stable in vesicles than on solid support, which
explains why no protein cosediments with POPC vesicles
are found (see Fig. 2).
We merely observed differences in the action of wt HIV-1
Nef and Nef G2A lacking the myristoyl anchor for their inter-
action with pure POPC bilayers. Although the myristoylation
motif MGxxxS is almost totally conserved in all HIV-1 Nef
alleles from different subtypes and stages of disease (1), the
role of Nef myristoylation is discussed controversially in
the literature. Early reports indicated that the N-terminal
myristoylation of HIV-1 Nef is required for membrane asso-
ciation and biological activity of the protein (10,11,13,40,41).
More recently, evidence has been presented that also nonmyr-
istoylated Nef can retain considerable membrane association
and functionality (14,42). In principle, it has been shown that
a single myristoyl moiety is not sufficient to stably anchor
a protein to the plasma membrane (17,18,43). Small
Biophysical Journal 96(8) 3242–3250
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unitary Gibbs free binding energy of ~8 kcal/mol, which
corresponds to an effective dissociation constant of only
104 M (44). Further energy contributions need to be
provided to stabilize the membrane-protein association such
as electrostatic interactions. At the N-terminus of Nef, the
propensity of a helix is found within the arginine-rich region
(arginines 17, 19, 21, 22), and this cluster of basic amino acids
facilitates the targeting of the protein to the plasmamembrane
and stabilizes the interaction with membranes (14,45,46). It is
also known that the N-terminal helical region of Nef associ-
ateswith a protein complex containingLck and a serine kinase
(16,47). These interactions with membrane-associated
proteins might additionally stabilize the membrane-protein
interaction in vivo.
Instead of protein binding, we found that Nef is capable of
disordering and perturbing the membrane assembly and that
the myristoyl group is not the only decisive determinant for
the action of the protein on lipidmembranes. It has been previ-
ously observed that the native myristoylated Nef protein
appears more compactly folded than its nonmyristoylated
variant, suggesting that the myristate associates with the
core domain structure of Nef, whereas without the lipid
moiety, the N-terminal residues remain flexible (19). Such
closed conformation would be in agreement with the sound
solubility of myristoylated Nef and its large cytosolic fraction
found in transfected cells (11–15,19). Accordingly, this
would imply the presence of a lipid-binding site on Nef that
recognizes its myristate. When associated to membranes,
this lipid recognition site may interact with hydrophobic
residues as the dileucine-based sorting motif of CD4 or other
lipids that are released from the bilayer, as suggested here.
Even though expression of Nef in mammalian cells does not
lead to detectable disruption of membranes, more subtle
destabilization processes might alter the properties of the
host plasma membranes. Of note, we recently identified that
the HIV-1 Nef protein modulates the lipid composition of
virions and host cell membrane microdomains (48). Perturba-
tions within certain regions of a membrane upon interaction
with Nef could at least contribute to such changes in lipid
composition and might directly impact on signal transduction
processes emanating from these domains or affect their lateral
mobility.
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